MR spectroscopy and diffusion tensor imaging of the brain in Sjögren-Larsson syndrome

Molecular Genetics and Metabolism

Volumn 98, Issue 4, 2009, Pages 367-371

  Sijens, P E ^a   Westerlaan, H E ^a   de Groot, J C ^a   Boon, M ^a   Potze, J H ^a   van Spronsen, F J ^b   Lunsing, R J ^a   Oudkerk, M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cerebral white matter; Diffusion tensor imaging; Lipid; Magnetic resonance spectroscopy; Sj gren Larsson syndrome

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ANISOTROPY; ARTICLE; CASE REPORT; CHILD; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; LATERAL BRAIN VENTRICLE; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; SJOEGREN LARSSON SYNDROME; WHITE MATTER;

ANISOTROPY; BRAIN; BRAIN MAPPING; CHILD, PRESCHOOL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PREGNANCY; SJOGREN-LARSSON SYNDROME;

EID: 70350619731     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.07.009     Document Type: Article

References (25)

1. Sjögren T., and Larsson T. Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psychiat. Neurol. Scand. 32 (1957) 1-113
2. Willemsen M.A.A.P., Ijlst L., Stijlen P.M., Rotteveel J.J., de Jong J.G.N., van Domburg P.H., Mayatepek E., Gabreëls F.J., and Wanders R.J. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 124 (2001) 1426-1437
3. Rizzo W.B., and Craft D.A. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol: NAD+ oxidoreductase in cultured fibroblasts. J. Clin. Invest. 88 (1991) 1643-1648
4. Kelson T.L., Secor McVoy Jr. J.R., and Rizzo W.B. Human liver fatty aldehyde dehydrogenase: microsomal localization. Purification, and biochemical characterization. Biochem. Biophys. Acta 1335 (1997) 99-110
5. James P.F., and Zoeller R.A. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjögren-Larsson syndrome. J. Biol. Chem. 272 (1997) 23532-23539
6. Verhoeven N.M., Jacobs C., Carney G., Somers M.P., Wanders R.J.A., and Rizzo W.B. Involvement of microsomal fatty aldehyde dehydrogenase in the α-oxidation of phytanic acid. FEBS Lett. 429 (1998) 225-228
7. Rizzo W.B., and Craft D.A. Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma. J. Lipid Res. 41 (2000) 1077-1081
8. Rizzo W.B., Heinz E., Simon M., and Craft D.A. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome. Biochim. Biophys. Acta 1531 (2000) 1-9
9. 4 in the Sjögren-Larsson syndrome. J. Neurol. Sci. 183 (2001) 61-67
10. Willemsen M.A.A.P., van der Graaf M., van der Knaap M.S., Heerschap A., van Domburg P.H.M.F., Gabreëls F.J.M., and Rotteveel J.J. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. Am. J. Neuroradiol. 25 (2004) 649-657
11. Lossos A., Khoury M., Rizzo W.B., Gomori J.M., Banin E., Zlotogorski A., Jaber S., Abramsky O., Argov Z., and Rosenmann H. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome. Arch. Neurol. 63 (2006) 278-280
12. 1H MRS findings of three patients with Sjögren-Larsson syndrome. Arg. Neuropsiqiatr. 64 Suppl. 2-B (2006) 398-401
13. Miyanomae Y., Ochi M., Yoshioka H., Takaya K., Kizaki Z., Inoue F., Furuya S., and Naruse S. Cerebral MRI and spectroscopy in Sjögren-Larsson syndrome: case report. Neuroradiology 37 (1995) 225-228
14. Mano T., Ono J., Kaminaga T., Imai K., Sukurai K., Harada K., Nagai T., Rizzo W.B., and Okada S. Proton MR spectroscopy of Sjögren-Larsson syndrome. Am. J. Neuroradiol. 20 (1999) 1671-1673
15. Pirgon O., Aydin K., and Atabek M.E. Proton magnetic resonance spectroscopic findings and clinical effects of montelukast sodium in a case with Sjögren-Larsson syndrome. J. Child Neurol. 21 (2006) 1092-1095
16. Rizzo W.B. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol. Genet. Metab. 90 (2007) 1-9
17. 1H MR spectroscopy and diffusion tensor imaging. Eur. Radiol. 15 (2005) 1686-1693
18. 1H spectroscopy for outcome prediction in severe traumatic brain injury: preliminary results. Crit. Care Med. 37 (2009) 1448-1455
19. Irwan R., Sijens P.E., Potze J.H., and Oudkerk M. Correlation of proton MR spectroscopy and diffusion tensor brain MR imaging. Magn. Reson. Imaging 23 (2005) 851-858
20. 1H Chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast agent. Magn. Reson. Med. 37 (1997) 222-225
21. Sijens P.E., Irwan R., Potze J.H., Mostert J.P., De Keyser J., and Oudkerk M. Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosis. Eur. Radiol. 16 (2006) 898-904
22. Bonekamp D., Nagae L.M., Degaonkar M., Matson M., Abdalla W.M.A., Barker P.B., Mori S., and Horská A. Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage 34 (2007) 733-742
23. Gordon N. Sjögren-Larsson syndrome. Dev. Med. Child Neurol. 49 (2007) 152-154
24. Rizzo W.B. Sjögren-Larsson syndrome: explaining the skin-brain connection. Neurology 52 (1999) 1307-1308
25. van Domburg P.H.M.F., Willemsen M.A.A.P., Rotteveel J.J., de Jong J.G.N., Thijssen H.O.M., Heerschap A., Cruysberg J.R.M., Wanders R.J.A., Gabreëls F.J.M., and Steijlen P.M. Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology 52 (1999) 1345-1352